MIRM
Mirum Pharmaceuticals Inc
NASDAQ: MIRM · HEALTHCARE · BIOTECHNOLOGY
$94.20
+0.21% today
Updated 2026-04-29
Market cap
$5.74B
P/E ratio
—
P/S ratio
11.02x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$40 – $109
Volume
0.8M
Mirum Pharmaceuticals Inc (MIRM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $11.00M | $19.14M | $77.06M | $186.37M | $336.89M | $521.31M |
| Revenue growth (YoY) | — | — | — | +74.0% | +302.7% | +141.8% | +80.8% | +54.7% |
| Cost of revenue | $0.00 | $324000.00 | $623000.00 | $1.90M | $12.37M | $47.04M | $81.64M | $100.58M |
| Gross profit | $0.00 | $-324000.00 | $-623000.00 | $17.23M | $64.69M | $139.34M | $255.25M | $420.73M |
| Gross margin | — | — | -5.7% | 90.1% | 83.9% | 74.8% | 75.8% | 80.7% |
| R&D | $2.33M | $42.99M | $81.61M | $131.43M | $106.84M | $102.61M | $140.63M | $186.18M |
| SG&A | $877500.00 | $11.75M | $22.69M | $50.02M | $16.96M | $139.58M | $190.72M | $257.03M |
| Operating income | $-2.92M | $-54.74M | $-104.30M | $-173.41M | $-131.22M | $-109.15M | $-87.61M | $-22.14M |
| Operating margin | — | — | -948.1% | -906.1% | -170.3% | -58.6% | -26.0% | -4.2% |
| EBITDA | $-17.33M | $-54.42M | $-102.31M | $-65.39M | $-122.85M | $-136.49M | $-48.97M | $17.21M |
| EBITDA margin | — | — | -930.1% | -341.7% | -159.4% | -73.2% | -14.5% | 3.3% |
| EBIT | $-21.71M | $-54.74M | $-102.93M | $-66.36M | $-126.09M | $-147.32M | $-72.60M | $-7.04M |
| Interest expense | $0.00 | $2.54M | $335000.00 | $17.59M | $15.98M | $15.11M | $14.31M | $14.39M |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-17.35M | $-52.55M | $-103.27M | $-83.99M | $-135.66M | $-163.41M | $-87.94M | $-23.36M |
| Net income growth (YoY) | — | -202.9% | -96.5% | +18.7% | -61.5% | -20.5% | +46.2% | +73.4% |
| Profit margin | — | — | -938.8% | -438.9% | -176.0% | -87.7% | -26.1% | -4.5% |